Drug Database
Back to search

Japan· JP-3999048G4027

ウパダシチニブ水和物

A upadacitinib product containing ウパダシチニブ水和物, registered in Japan by アッヴィ, on the national reimbursement list. The same ATC class is registered in 13 of our 19 countries.

On Japan’s NHI price listATC L04AF03

Checked against MHLW / PMDA (Japan) on

Informational only — not a medical device.

SOURCE REGISTER · JPMHLW / PMDA (Japan)normalisedウパダシチニブ水和物ATCL04AF03REGISTER NO.JP-3999048G4027PACKS LISTED0CHECKEDSeptember 25, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about ウパダシチニブ水和物Answers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Upadacitinib is registered in 13 of 19 countries.

Countries holding a registration under ATC L04AF03 (upadacitinib), each read from that country’s own register.

  • This record: Japan, from MHLW / PMDA (Japan)
  • 8 of them publish a price we can compare per daily dose
Search upadacitinib products by name

Upadacitinib · ATC L04AF03

13 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of upadacitinib costs, country by country.

Normalised to the WHO defined daily dose (15 mg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Upadacitinib · price per daily dose (15 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$32.01
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

MHLW / PMDA (Japan)
Active substance
ウパダシチニブ水和物
Manufacturer
アッヴィ
Country
Japan (JP)
ATC code
L04AF03
ATC class
Upadacitinib
Defined daily dose
15 mg, O
Reimbursed
Yes
Source register
MHLW / PMDA (Japan)
Last checked
September 25, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

407 interactions on record for upadacitinib.

Graded by severity as the source publishes them — 337 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check upadacitinib against other medicinesHow interaction checks work

Upadacitinib · interactions on record

407 records

  • 337 severe
  • 63 moderate
  • 7 minor

Most severe, free to view

  • PrednisoloneA07EA01severe
  • HydrocortisoneA07EA02severe
  • PrednisoneA07EA03severe
  • BetamethasoneA07EA04severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same class

Other records under L04AF03

Upadacitinib, as other registers publish it.

All upadacitinib products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ba5754e3-e8bf-44ac-9af3-6e1f72521b71
GET /v1/drugs/ba5754e3-e8bf-44ac-9af3-6e1f72521b71?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "spec": "４５ｍｇ１錠",
  "marks": null,
  "source": "mhlw",
  "remarks": null,
  "yj_code": "3999048G4027",
  "category": "内用薬",
  "price_yen": 8226,
  "generic_name": "ウパダシチニブ水和物",
  "product_name_jp": null,
  "therapeutic_class": "3999",
  "transitional_expiry": null
}
API referenceMCP serverPlans

See everything about upadacitinib.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console